Caspofungin treatment in two infants with persistent fungaemia due to Candida lipolytica

Scand J Infect Dis. 2006;38(6-7):559-62. doi: 10.1080/00365540500404052.

Abstract

Candida lipolytica has infrequently been identified as a cause of infection and is associated mostly with vascular catheter-related fungaemia. Patients reported in the literature have been successfully treated with catheter removal or amphotericin B treatment. We report 2 infants with C. lipolytica fungaemia unresponsive to catheter removal and amphotericin B therapy and treated successfully with the addition of caspofungin to amphotericin B.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / administration & dosage
  • Antifungal Agents / administration & dosage*
  • Candida / isolation & purification
  • Caspofungin
  • Catheters, Indwelling / adverse effects
  • Catheters, Indwelling / microbiology
  • Cross Infection / drug therapy*
  • Cross Infection / microbiology
  • Drug Therapy, Combination
  • Echinocandins
  • Female
  • Fungemia / diagnosis
  • Fungemia / drug therapy*
  • Humans
  • Infant
  • Infant, Newborn
  • Lipopeptides
  • Male
  • Peptides, Cyclic / administration & dosage

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Peptides, Cyclic
  • Amphotericin B
  • Caspofungin